NASDAQ · Biotechnology

CRISPR Therapeutics AG (CRSP) Stock

$53.39 +5.85% NASDAQ: CRSP Healthcare

Valuation

MetricValue
Price$53.39
Market Cap$5.15B
P/E Ratio-11.62
P/B Ratio3.06
P/S Ratio398.41
EPS (TTM)$0.00
52-Week High$78.48
52-Week Low$44.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-24.39%
ROA-17.02%
ROCE-21.12%
Gross Margin-14200.00%
Operating Margin-89.33%
Net Margin-138.57%
Debt/Equity0.45
Current Ratio17.97

Annual Financials (USD)

Metric20212022202320242025
Revenue$913.0M$0$370.0M$35.0M$4.0M
Operating Profit$374.0M$-673.0M$-223.0M$-467.0M$-568.0M
Net Profit$378.0M$-650.0M$-154.0M$-366.0M$-582.0M
EPS$4.70$-8.36$-1.94$-4.34$-6.47
Op Margin40.9%-154394.7%-60.1%-1333.0%-16191.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.8B$2.2B$2.2B$2.2B$2.3B
Total Liabilities$352.0M$368.0M$347.0M$310.0M$343.0M
Cash$923.0M$212.0M$389.0M$298.0M$355.0M
Borrowings$225.0M$244.0M$239.0M$224.0M$395.0M

Latest News

CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on It Zacks · Jul 14, 2026 CRISPR Therapeutics AG (CRSP) Stock Dips While Market Gains: Key Facts Zacks · Jul 10, 2026 3 Reasons to Buy CRISPR Therapeutics Stock Motley Fool · Jul 10, 2026 NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock? Zacks · Jul 9, 2026 Vertex’s Crinetics Deal Balances Growth with Integration Risk MarketBeat · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$539.0M$-496.0M$-260.0M$-143.0M$-345.0M
Investing Cash Flow$-1.1B$-296.0M$365.0M$-282.0M$-33.0M
Financing Cash Flow$38.0M$38.0M$0$31.0M$0
Net Cash Flow$-246.0M$-716.0M$178.0M$-91.0M$49.0M
Free Cash Flow$457.0M$-533.0M$-270.0M$-145.0M$-346.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-2.59
EV / EBITDA-12.84
FCF Yield-9.01%
Quick Ratio17.85
Interest Coverage0.00
Return 1Y8.09%
Return 3Y12.65%
Return 5Y-53.33%

Ownership

Insiders Held5.91%
Institutions Held79.34%
Institutions Float Held84.33%
Institutional HolderSharesReport Date
ARK Investment Management, LLC11,313,6232026-03-31
Blackrock Inc.7,680,0732026-03-31
Orbis Allan Gray Ltd6,106,0112026-03-31
Capital World Investors4,725,0372026-03-31
State Street Corporation3,982,5002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BEAMBeam Therapeutics Inc. $25.70 +4.47% -29.88 $2.64B 0.00%
DNAGinkgo Bioworks Holdings, Inc. $13.00 +14.64% -2.46 $849.22M 0.00%
DTILPrecision BioSciences, Inc. $6.72 +4.51% -2.26 $185.48M 0.00%
EDITEditas Medicine, Inc. $2.95 +4.04% -3.50 $453.45M 0.00%
MGXMetagenomi Therapeutics, Inc. $1.00 +0.68% -0.42 $37.65M 0.00%

About CRISPR Therapeutics AG

CRISPR Therapeutics AG (CRSP) stock trades at $53.39 with a market capitalization of $5.15B. The stock is valued at a price-to-earnings (P/E) ratio of -11.62, price-to-book of 3.06, price-to-sales of 398.41. Over the past 52 weeks the stock has ranged between $44.12 and $78.48, and currently trades 32.0% below its 52-week high.

On profitability, CRISPR Therapeutics AG generates a return on equity (ROE) of -24.39%, return on capital employed of -21.12%, an operating margin of -89.33%, a net profit margin of -138.57%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides